33
/it/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2307057
194118
2
Public Timelines
FAQ Ricevere il Premium

1 gen 2011 anni - HPTN 052 trial shows 96% reduced risk of onfection in serodiscordant couples. FDA approves Complera a second all-in- one combination tablet.

Aggiunto al nastro di tempo:

Data:

1 gen 2011 anni
Adesso
~ 14 years ago